COPD - is one exacerbation enough?
Chronic obstructive pulmonary disease (COPD) remains one of the most prevalent pulmonary diseases worldwide, causing significant morbidity and mortality. The recent GOLD guidelines have changed the classification of COPD from the previous ABCD system to an ABE classification, with the E category rep...
Saved in:
Published in | African journal of thoracic and critical care medicine Vol. 29; no. 3; p. 142 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
South African Medical Association NPC
01.09.2023
South African Medical Association |
Online Access | Get full text |
Cover
Loading…
Summary: | Chronic obstructive pulmonary disease (COPD) remains one of the most prevalent pulmonary diseases worldwide, causing significant morbidity and mortality. The recent GOLD guidelines have changed the classification of COPD from the previous ABCD system to an ABE classification, with the E category representing those with one severe exacerbation, or two or more moderate exacerbations.[1] This is a clinically important threshold, as patients with category E disease are commonly given inhaled corticosteroid (ICS) therapy, while it is often withheld from category A and B patients. With the goal of examining the validity of this threshold, Vanfleteren and colleagues[2] have recently published a nationwide cohort study based on over 45 000 patients in the Swedish National Airway Register. They divided the patients into the GOLD groups and added a 0 or a 1 for category A and B patients, with a 1 indicating that a patient had a prior moderate exacerbation and 0, none. The groups were followed up and exacerbation rates, hospitalisation, and mortality compared. |
---|---|
ISSN: | 2617-0191 2617-0205 |
DOI: | 10.10520/ejc-m_ajtccm_v29_n3_a12 |